These results suggest that CCT modulates the expression of adipokines, enhancing levels of the anti-inflammatory and insulin-sensitising adiponectin and decreasing levels of the pro-inflammatory and insulin-resistance-promoting resistin. The gene discussed is RETN; the disease is Insulin resistance.